Maynard Um
-
-
-
-
-
-
-
Janux Therapeutics (JANX) PT Lowered to $45 at H.C. Wainwright
-
-
-
-
-
-
-
Why UBS says Q4 is eventful for SMID oncology stocks
-
-
-
-
-
-
-
Raymond James Starts Janux Therapeutics (JANX) at Outperform
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Janux Therapeutics (JANX)
-
-
-
-
-
-
-
Janux Therapeutics (JANX) PT Raised to $115 at Stifel
-
-
-
-
-
-
-
Janux Therapeutics (JANX) PT Raised to $100 at BTIG, 'The World Is Not Enough — 007 Strikes Again Exceeding The Street's Highest Expectations'
-
-
-
-
-
-
-
UBS Starts Janux Therapeutics (JANX) at Buy
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

